Fundamentals of Chemotherapy Immunotherapy Administration Practice Test 2026 – All-in-One Guide to Master Your Exam Success!

Monitoring the Complete Blood Count (CBC) is crucial for assessing the risk of complications from chemotherapy because chemotherapy agents can significantly affect bone marrow function, which is responsible for producing red blood cells, white blood cells, and platelets. A CBC provides valuable information about these components of blood, allowing healthcare providers to detect conditions such as anemia, leukopenia (low white blood cell count), and thrombocytopenia (low platelet count).

Anemia resulting from low red blood cell counts can lead to fatigue and weakness. Low white blood cell counts increase the risk of infection, which is a common and serious complication for patients undergoing chemotherapy. Additionally, low platelet counts can lead to bleeding and bruising, complicating patient management. Regular CBC monitoring helps healthcare teams anticipate these complications and intervene appropriately, adjusting chemotherapy regimens or providing supportive care as necessary.

While monitoring cholesterol levels provides useful information regarding cardiovascular risk, and thyroid function tests can help evaluate metabolic disorders, they are not directly related to the complications commonly associated with chemotherapy. Coagulation profiles are important for certain conditions but are not as critical for the routine monitoring of chemotherapy-related effects on bone marrow. Thus, the CBC stands out as the most vital lab value to monitor in this context.